[1]
Tiwari, M. et al. 2025. Role of Tyrosine Kinase Inhibitor (TKI) in stage IV adenocarcinoma of lung: Early outcome from tertiary cancer hospital. Nepalese Journal of Cancer. 9, 2 (Sep. 2025), 53–57. DOI:https://doi.org/10.3126/njc.v9i2.84922.